Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$2.63
+5.20%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
7.97x
PEG TTM
—
Price / book
2.51x
Price / sales
—
Price / cash flow
-5.29x

Enterprise value

Enterprise value
$14.9M
EV / sales
—
EV / EBITDA
-3.88x
EV / EBIT
-2.15x
Market cap
$15.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026